powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1831507367
Bob Li
MBBS, MPH, FRACP
Medical Oncology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
285
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
16
Brand share
38.2%
Top prescribed drugs
Osimertinib Mesylate
54 claims
Ondansetron Hcl
22 claims
Megestrol Acetate
20 claims
Dacomitinib
17 claims
Dexamethasone
16 claims
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
107
Unique beneficiaries
—
Total services
239
Distinct HCPCS
4
Medicare payment
$28K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — below median (cohort median 458).